期刊文献+

双侧乳腺癌保乳术后不同放疗技术的心肺受量比较

Comparison of cardiopulmonary tolerance with different radiotherapy techniques after breast-conserving surgery for bilateral breast cancer
下载PDF
导出
摘要 目的:对比早期双侧乳腺癌容积弧形旋转调强(VMAT)技术和调强放射治疗(IMRT)技术的剂量学差异,为临床选择提供参考。方法:收集我院放疗科2018年1月至2021年10月收治的早期双侧乳腺癌行双侧胸壁放射治疗的患者10例,病例分期均为Ⅰ和Ⅱ期,靶区处方剂量均为50Gy/25f。在医科达Monaco TPS上分别为每位患者设计VMAT计划和IMRT计划,对比靶区高剂量包绕体积V_(5250)、V_(5350)、V_(5500)、平均剂量(D_(mean))、均匀性指数(HI)、适形指数(CI)及重要危及器官的受量等。结果:将VMAT计划和IMRT计划的靶区处方剂量归一至包绕95%靶体积,VMAT计划靶区高剂量包绕体积V_(5250)、V_(5350)、V_(5500)和D_(mean)与IMRT计划相比差异无统计学意义(P>0.05),而CI优于IMRT计划(P<0.05),HI差于VMAT计划(P<0.05)。VMAT计划中全肺的V5、心脏的V5均高于IMRT计划(P<0.05),全肺的V_(10)、V_(20)、V_(30)均低于IMRT计划(P<0.05),全肺的D_(mean)、心脏的V_(10)、V_(20)、V_(30)和D_(mean)与IMRT计划相比均无统计学差异(P>0.05)。结论:早期双侧乳腺癌基于Monaco TPS的放疗计划设计中,VMAT技术和IMRT技术均能满足临床要求,两者相比,VMAT技术提高了靶区剂量适形度,在双肺的保护上优于IMRT计划,故临床应用中建议多考虑VMAT技术。
作者 陶娜 郭晴 成坚强 牛瑞军 魏玺仪 陶发利 刘婷婷 安永伟 魏世鸿 TAO Na;GUO Qing;CHENG Jianqiang;NIU Ruijun;WEI Xiyi;TAO Fali;LIU Tingting;AN Yongwei;WEI Shihong
机构地区 甘肃省肿瘤医院
出处 《甘肃医药》 2024年第1期13-16,共4页 Gansu Medical Journal
基金 甘肃省卫生健康行业科研计划项目(编号:GSWSKY-2021-052) 精准放疗星火计划科研公益项目(编号:2019-N-11-17)。
  • 相关文献

参考文献10

二级参考文献80

  • 1Roder D, Silva P, Zorbas H, et al. Survival from synchronous bilateral breast cancer: the experience of surgeons participating in the breast audit of the Society of Breast Surgeons of Australia and New Zealand [J]. Asian Pae J Cancer Prey, 2012,13 (4) : 1413-1418.
  • 2Baycan D, Karacetin D, Balkanay AY, et al. Field-in-field IMRT versus 3D-CRT of the breast. Cardiac vessels, ipsilateral lung, and contralateral breast absorbed doses in patients with left sided lumpectomy a dosimetric comparison [J]. Jpn J Radiol,2012,30(10) 819-823.
  • 3Agrawal S, Kumar S, Lawrence A, et al. Ipsilateral lung dose volume parameters predict radiation pneumonitis in addition to classical dose volume parameters in locally advanced NSCLC treated with combined modality therapy [J]. South Asian J Cancer,2014,3(1) : 13-15.
  • 4Darby SC, Ewertz M, McGale P, et al. Risk of ischemic heart disease in women after radiotherapy for breast cancer[J]. N Engl J Med,2013,368(11) :987-998.
  • 5Shah JP, Lydiatt W. Treatment of cancer of the head and neck[J]. CA Cancer J Clin, 1995, 45: 352-368.
  • 6Tham IW, Hee SW, Yeo RM, et al. Treatment of nasopharyngeal carcinoma using intensity-modulated radiotherapy-the National cancer centre Singapore experience[J]. Int I Radiat Oncol Biol Phys, 2009, 75(5): 1481-1486.
  • 7Kam MK, Teo PM, Chau RM, et al. Treatment of nasopharyngeal carcinoma with intensity-modulated radiotherapy: the Hong Kong experience[J].Int J Radiat Oncol Biol Phys, 2004, 60(5): 1440-1450.
  • 8Ezzell GA, Galvin JM, Low D, et al. Guidance document on delivery, treatment planning, and clinical implementation of IMRT: report of the IMRT Subcommittee of the AAPM Radiation Therapy Committee[J]. Med Phys, 2003, 30(8): 2089-2115.
  • 9Hoogeman MS, Nuyttens JJ, Levendag PC, et al. Time dependence of intrafraction patient motion assessed by repeat stereoscopic imaging[J]. Int J Radiat Oncol Biol Phys, 2008, 70(2): 609-618.
  • 10Hall El. Intensity-modulated radiation therapy, protons, and the risk of second cancers[J]. Int J Radiat Oncol Biol Phys, 2006, 65(1): 1-7.

共引文献424

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部